| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 6.50 Billion | USD 11.53 Billion | 5.9% | 2024 |
FrequentlyAsked Questions
The global respiratory diagnostics market is expected to grow due to increasing prevalence of respiratory diseases (like asthma and COPD), air pollution, and adoption of advanced diagnostic technologies.
According to a study, the global respiratory diagnostics market size was worth around USD 6.50 Billion in 2024 and is expected to reach USD 11.53 Billion by 2034.
The global respiratory diagnostics market is expected to grow at a CAGR of 5.9% during the forecast period.
North America is expected to dominate the respiratory diagnostics market over the forecast period.
Leading players in the global respiratory diagnostics market include Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Medtronic, COSMED srl, NIHON KOHDEN CORPORATION, F. Hoffmann-La Roche Ltd, Drägerwerk AG & Co. KGaA, GC Diagnostics Corporation, Bio-Rad Laboratories, Inc., Masimo, bioMérieux SA, Carestream Health, Novartis AG, Thermo Fisher Scientific Inc., Abbott, Johnson & Johnson Services, Inc, GlaxoSmithKline plc, Bayer AG and BD, among others., among others.
The report explores crucial aspects of the respiratory diagnostics market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients